 | • レポートコード：QYR9ST05768 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、多発性筋炎治療の世界市場について調査・分析し、多発性筋炎治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（免疫抑制剤、アルキル化剤、免疫グロブリン、モノクローナル抗体、コルチコステロイド）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多発性筋炎治療市場動向 ・主要企業別マーケットシェア ・多発性筋炎治療の種類別市場規模2014-2019 （免疫抑制剤、アルキル化剤、免疫グロブリン、モノクローナル抗体、コルチコステロイド） ・多発性筋炎治療の用途別市場規模2014-2019 （病院、診療所、その他） ・多発性筋炎治療の北米市場：主要企業・種類別/用途別市場規模 ・多発性筋炎治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・多発性筋炎治療の中国市場：主要企業・種類別/用途別市場規模 ・多発性筋炎治療の日本国内市場：主要企業・種類別/用途別市場規模 ・多発性筋炎治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・多発性筋炎治療のインド市場：主要企業・種類別/用途別市場規模 ・多発性筋炎治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Hospira, Inc.、Antares Pharma, Inc.、Medexus Pharma, Inc.、Fresenius SE & Co. KGaA、Mylan N.V.、Alcami Corporation、Teva Pharmaceuticals、Novartis AG、Genentech, Inc.） ・多発性筋炎治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Polymyositis (PM) is a type of chronic inflammation of the muscles (inflammatory myopathy) related to dermatomyositis and inclusion body myositis. Its name means “inflammation of many muscles” (poly- + myos- + -itis).In 2018, the global Polymyositis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Polymyositis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Polymyositis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Hospira, Inc.
Antares Pharma, Inc.
Medexus Pharma, Inc.
Fresenius SE & Co. KGaA
Mylan N.V.
Alcami Corporation
Teva Pharmaceuticals
Novartis AG
Genentech, Inc.
Market segment by Type, the product can be split into
Immunosuppressant
Alkylating Agent
Immunoglobulin
Monoclonal Antibodies
Corticosteroids
Market segment by Application, split into
Hospitals
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Polymyositis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Polymyositis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Polymyositis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Polymyositis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunosuppressant
1.4.3 Alkylating Agent
1.4.4 Immunoglobulin
1.4.5 Monoclonal Antibodies
1.4.6 Corticosteroids
1.5 Market by Application
1.5.1 Global Polymyositis Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Polymyositis Treatment Market Size
2.2 Polymyositis Treatment Growth Trends by Regions
2.2.1 Polymyositis Treatment Market Size by Regions (2019-2025)
2.2.2 Polymyositis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Polymyositis Treatment Market Size by by Players
3.1.1 Global Polymyositis Treatment Revenue by by Players (2014-2019)
3.1.2 Global Polymyositis Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Polymyositis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Polymyositis Treatment Key Players Head office and Area Served
3.3 Key Players Polymyositis Treatment Product/Solution/Service
3.4 Date of Enter into Polymyositis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Polymyositis Treatment Market Size by Type (2014-2019)
4.2 Global Polymyositis Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Polymyositis Treatment Market Size (2014-2019)
5.2 Polymyositis Treatment Key Players in North America
5.3 North America Polymyositis Treatment Market Size by Type
5.4 North America Polymyositis Treatment Market Size by Application
6 Europe
6.1 Europe Polymyositis Treatment Market Size (2014-2019)
6.2 Polymyositis Treatment Key Players in Europe
6.3 Europe Polymyositis Treatment Market Size by Type
6.4 Europe Polymyositis Treatment Market Size by Application
7 China
7.1 China Polymyositis Treatment Market Size (2014-2019)
7.2 Polymyositis Treatment Key Players in China
7.3 China Polymyositis Treatment Market Size by Type
7.4 China Polymyositis Treatment Market Size by Application
8 Japan
8.1 Japan Polymyositis Treatment Market Size (2014-2019)
8.2 Polymyositis Treatment Key Players in Japan
8.3 Japan Polymyositis Treatment Market Size by Type
8.4 Japan Polymyositis Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Polymyositis Treatment Market Size (2014-2019)
9.2 Polymyositis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Polymyositis Treatment Market Size by Type
9.4 Southeast Asia Polymyositis Treatment Market Size by Application
10 India
10.1 India Polymyositis Treatment Market Size (2014-2019)
10.2 Polymyositis Treatment Key Players in India
10.3 India Polymyositis Treatment Market Size by Type
10.4 India Polymyositis Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Polymyositis Treatment Market Size (2014-2019)
11.2 Polymyositis Treatment Key Players in Central & South America
11.3 Central & South America Polymyositis Treatment Market Size by Type
11.4 Central & South America Polymyositis Treatment Market Size by Application
12 International Players Profiles
12.1 Hospira, Inc.
12.1.1 Hospira, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Polymyositis Treatment Introduction
12.1.4 Hospira, Inc. Revenue in Polymyositis Treatment Business (2014-2019))
12.1.5 Hospira, Inc. Recent Development
12.2 Antares Pharma, Inc.
12.2.1 Antares Pharma, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Polymyositis Treatment Introduction
12.2.4 Antares Pharma, Inc. Revenue in Polymyositis Treatment Business (2014-2019)
12.2.5 Antares Pharma, Inc. Recent Development
12.3 Medexus Pharma, Inc.
12.3.1 Medexus Pharma, Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Polymyositis Treatment Introduction
12.3.4 Medexus Pharma, Inc. Revenue in Polymyositis Treatment Business (2014-2019)
12.3.5 Medexus Pharma, Inc. Recent Development
12.4 Fresenius SE & Co. KGaA
12.4.1 Fresenius SE & Co. KGaA Company Details
12.4.2 Company Description and Business Overview
12.4.3 Polymyositis Treatment Introduction
12.4.4 Fresenius SE & Co. KGaA Revenue in Polymyositis Treatment Business (2014-2019)
12.4.5 Fresenius SE & Co. KGaA Recent Development
12.5 Mylan N.V.
12.5.1 Mylan N.V. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Polymyositis Treatment Introduction
12.5.4 Mylan N.V. Revenue in Polymyositis Treatment Business (2014-2019)
12.5.5 Mylan N.V. Recent Development
12.6 Alcami Corporation
12.6.1 Alcami Corporation Company Details
12.6.2 Company Description and Business Overview
12.6.3 Polymyositis Treatment Introduction
12.6.4 Alcami Corporation Revenue in Polymyositis Treatment Business (2014-2019)
12.6.5 Alcami Corporation Recent Development
12.7 Teva Pharmaceuticals
12.7.1 Teva Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Polymyositis Treatment Introduction
12.7.4 Teva Pharmaceuticals Revenue in Polymyositis Treatment Business (2014-2019)
12.7.5 Teva Pharmaceuticals Recent Development
12.8 Novartis AG
12.8.1 Novartis AG Company Details
12.8.2 Company Description and Business Overview
12.8.3 Polymyositis Treatment Introduction
12.8.4 Novartis AG Revenue in Polymyositis Treatment Business (2014-2019)
12.8.5 Novartis AG Recent Development
12.9 Genentech, Inc.
12.9.1 Genentech, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Polymyositis Treatment Introduction
12.9.4 Genentech, Inc. Revenue in Polymyositis Treatment Business (2014-2019)
12.9.5 Genentech, Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Polymyositis Treatment Key Market Segments
Table Key Players Polymyositis Treatment Covered
Table Global Polymyositis Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Immunosuppressant Figures
Table Key Players of Immunosuppressant
Figuer Alkylating Agent Figures
Table Key Players of Alkylating Agent
Figuer Immunoglobulin Figures
Table Key Players of Immunoglobulin
Figuer Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figuer Corticosteroids Figures
Table Key Players of Corticosteroids
Table Global Polymyositis Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Polymyositis Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Polymyositis Treatment Report Years Considered
Figure Global Polymyositis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Polymyositis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Polymyositis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Polymyositis Treatment Market Share by Regions 2014-2019
Figure Global Polymyositis Treatment Market Share by Regions 2014-2019
Figure Global Polymyositis Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Polymyositis Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Polymyositis Treatment Market Share by by Players (2014-2019)
Figure Global Polymyositis Treatment Market Share by by Players in 2018
Table Global Polymyositis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Polymyositis Treatment Product/Solution/Service
Table Date of Enter into Polymyositis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Polymyositis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Polymyositis Treatment Market Size Share by Type (2014-2019)
Figure Global Polymyositis Treatment Market Size Market Share by Type (2014-2019)
Table Global Polymyositis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Polymyositis Treatment Market Size Share by Application (2014-2019)
Figure Global Polymyositis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Polymyositis Treatment Revenue Market Share by Application in 2018
Figure North America Polymyositis Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Polymyositis Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Polymyositis Treatment Market Share (2018-2019)
Table North America Polymyositis Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Polymyositis Treatment Market Share by Type 2014-2019
Table North America Polymyositis Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Polymyositis Treatment Market Share by Application 2014-2019
Figure Europe Polymyositis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Polymyositis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Polymyositis Treatment Market Share (2018-2019)
Table Europe Polymyositis Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Polymyositis Treatment Market Share by Type 2014-2019
Table Europe Polymyositis Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Polymyositis Treatment Market Share by Application 2014-2019
Figure China Polymyositis Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Polymyositis Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Polymyositis Treatment Market Share (2018-2019)
Table China Polymyositis Treatment Market Size by Type 2014-2019 (Million US$)
Table China Polymyositis Treatment Market Share by Type 2014-2019
Table China Polymyositis Treatment Market Size by Application 2014-2019 (Million US$)
Table China Polymyositis Treatment Market Share by Application 2014-2019
Figure Japan Polymyositis Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Polymyositis Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Polymyositis Treatment Market Share (2018-2019)
Table Japan Polymyositis Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Polymyositis Treatment Market Share by Type 2014-2019
Table Japan Polymyositis Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Polymyositis Treatment Market Share by Application 2014-2019
Figure Southeast Asia Polymyositis Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Polymyositis Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Polymyositis Treatment Market Share (2018-2019)
Table Southeast Asia Polymyositis Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Polymyositis Treatment Market Share by Type 2014-2019
Table Southeast Asia Polymyositis Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Polymyositis Treatment Market Share by Application 2014-2019
Figure India Polymyositis Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Polymyositis Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Polymyositis Treatment Market Share (2018-2019)
Table India Polymyositis Treatment Market Size by Type 2014-2019 (Million US$)
Table India Polymyositis Treatment Market Share by Type 2014-2019
Table India Polymyositis Treatment Market Size by Application 2014-2019 (Million US$)
Table India Polymyositis Treatment Market Share by Application 2014-2019
Figure Central & South America Polymyositis Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Polymyositis Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Polymyositis Treatment Market Share (2018-2019)
Table Central & South America Polymyositis Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Polymyositis Treatment Market Share by Type 2014-2019
Table Central & South America Polymyositis Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Polymyositis Treatment Market Share by Application 2014-2019
Table Hospira, Inc. Company Details
Table Hospira, Inc. Revenue in Polymyositis Treatment Business 2014-2019 (Million US$)
Figure Hospira, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2014-2019)
Table Hospira, Inc. Recent Development
Table Antares Pharma, Inc. Company Details
Table Antares Pharma, Inc. Revenue in Polymyositis Treatment Business 2014-2019 (Million US$)
Figure Antares Pharma, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2014-2019)
Table Antares Pharma, Inc. Recent Development
Table Medexus Pharma, Inc. Company Details
Table Medexus Pharma, Inc. Revenue in Polymyositis Treatment Business 2014-2019 (Million US$)
Figure Medexus Pharma, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2014-2019)
Table Medexus Pharma, Inc. Recent Development
Table Fresenius SE & Co. KGaA Company Details
Table Fresenius SE & Co. KGaA Revenue in Polymyositis Treatment Business 2014-2019 (Million US$)
Figure Fresenius SE & Co. KGaA Revenue Growth Rate in Polymyositis Treatment Business (2014-2019)
Table Fresenius SE & Co. KGaA Recent Development
Table Mylan N.V. Company Details
Table Mylan N.V. Revenue in Polymyositis Treatment Business 2014-2019 (Million US$)
Figure Mylan N.V. Revenue Growth Rate in Polymyositis Treatment Business (2014-2019)
Table Mylan N.V. Recent Development
Table Alcami Corporation Company Details
Table Alcami Corporation Revenue in Polymyositis Treatment Business 2014-2019 (Million US$)
Figure Alcami Corporation Revenue Growth Rate in Polymyositis Treatment Business (2014-2019)
Table Alcami Corporation Recent Development
Table Teva Pharmaceuticals Company Details
Table Teva Pharmaceuticals Revenue in Polymyositis Treatment Business 2014-2019 (Million US$)
Figure Teva Pharmaceuticals Revenue Growth Rate in Polymyositis Treatment Business (2014-2019)
Table Teva Pharmaceuticals Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Polymyositis Treatment Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Polymyositis Treatment Business (2014-2019)
Table Novartis AG Recent Development
Table Genentech, Inc. Company Details
Table Genentech, Inc. Revenue in Polymyositis Treatment Business 2014-2019 (Million US$)
Figure Genentech, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2014-2019)
Table Genentech, Inc. Recent Development
Table Global Polymyositis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Polymyositis Treatment Market Size Share by Regions (2019-2025)
Figure Global Polymyositis Treatment Market Size Share by Regions in 2025
Figure North America Polymyositis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Polymyositis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Polymyositis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Polymyositis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Polymyositis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Polymyositis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Polymyositis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Polymyositis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Polymyositis Treatment Market Size by Product (2019-2025)
Figure Global Polymyositis Treatment Market Size by Product in 2025
Table Global Polymyositis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Polymyositis Treatment Market Size by Application (2019-2025)
Figure Global Polymyositis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
多発性筋炎治療の世界市場：市場規模・現状・予測 Polymyositis (PM) is a type of chronic inflammation of the muscles (inflammatory myopathy) related to dermatomyositis and inclusion body myositis. Its name means "inflammation of many muscles" (poly- + myos- + -itis).In 2018, the global Polymyositis Treatment market size was xx million US$ and it is…- 乳がんモノクローナル抗体の世界市場：市場規模・現状・予測 Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…
- がんモノクローナル抗体の世界市場：インサイト・予測 The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…
- 菌状息肉腫治療の世界市場：市場規模・現状・予測 Mycosis fungoides is most frequently encountered in primary cutaneous lymphoma. The disease progression is slow and indolent with a challenging diagnosis in the early stage of the disease which requires accurate clinical-histopathological correlation. It is a rare disease occurs usually in adults ab…
- 腎臓癌治療薬の世界市場：市場規模・現状・予測 Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. In 2018, the gl…